Abstract

Chronic hepatitis B (HBV) and C (HCV) virus infections are the most important factors associated with hepatocellular carcinoma (HCC), but tumor prognosis remains poor due to the lack of diagnostic biomarkers. In order to identify novel diagnostic markers and therapeutic targets, the gene expression profile associated with viral and non-viral HCC was assessed in 9 tumor samples by oligo-microarrays. The differentially expressed genes were examined using a z-score and KEGG pathway for the search of ontological biological processes. We selected a non-redundant set of 15 genes with the lowest P value for clustering samples into three groups using the non-supervised algorithm k-means. Fisher's linear discriminant analysis was then applied in an exhaustive search of trios of genes that could be used to build classifiers for class distinction. Different transcriptional levels of genes were identified in HCC of different etiologies and from different HCC samples. When comparing HBV-HCC vs HCV-HCC, HBV-HCC/HCV-HCC vs non-viral (NV)-HCC, HBC-HCC vs NV-HCC, and HCV-HCC vs NV-HCC of the 58 non-redundant differentially expressed genes, only 6 genes (IKBKbeta, CREBBP, WNT10B, PRDX6, ITGAV, and IFNAR1) were found to be associated with hepatic carcinogenesis. By combining trios, classifiers could be generated, which correctly classified 100% of the samples. This expression profiling may provide a useful tool for research into the pathophysiology of HCC. A detailed understanding of how these distinct genes are involved in molecular pathways is of fundamental importance to the development of effective HCC chemoprevention and treatment.

Highlights

  • Hepatocellular carcinoma (HCC), the most important primary malignant tumor of the liver, is one of the human cancers clearly linked to viral infection [1]

  • To identify differences in gene expression between HCC of different etiologies we compared mRNA samples prepared from the three groups, i.e., hepatitis B virus (HBV)-HCC, hepatitis C virus (HCV)-HCC and NV-HCC

  • Using the Wilcoxon test, we identified differentially expressed genes for four comparisons: HBV-HCC vs HCV-HCC (1141 genes), HBV-HCC/HCV-HCC vs NV-HCC (2257 genes), HBV-HCC vs NV-HCC (1671 genes) and HCV-HCC vs NV-HCC (1584 genes)

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC), the most important primary malignant tumor of the liver, is one of the human cancers clearly linked to viral infection [1]. Some individuals who develop HCC are not infected with HCV or HBV, and do not have cirrhosis in the surrounding parenchyma. HCC mortality has significantly decreased with the development of new surgical techniques, about 60-100% of these patients suffer an HCC recurrence even after curative resection, and this has become the most important factor that limits the long-term survival of HCC patients. Considering the complexity of hepatocarcinogenesis, many genes are probably involved in the initiation and progression of this cancer, and comprehensive expression analysis using microarray technology has a great potential for the discovery of new genes involved in this process [8].

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.